comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.
comirnaty concentrado para suspensión para inyección 5/5 µg/dosis (vacuna sars-cov-2 arnm tozinamerán/famtozinamerán)
pfizer chile s.a. - tozinameran; famtozinameran - famtozinamerÁn (2) 5,00 mcg; tozinamerÁn (1) 5,00 mcg - inmunización activa para prevenir la enfermedad por coronavirus 2019 (covid 19) causada por el virus sars-cov-2, en personas de 5 años a 11 años de edad.
comirnaty suspensión para inyección 15/15 µg/dosis (vacuna sars-cov-2 arnm tozinamerán/famtozinamerán)
pfizer chile s.a. - tozinameran; famtozinameran - famtozinamerÁn (2) 15,00 mcg; tozinamerÁn (1) 15,00 mcg - inmunización activa con el fin de prevenir la covid-19 causada por el sars-cov-2, en individuos de 12 años y mayores.
comirnaty concentrado para suspensión para inyección 3 µg/dosis (vacuna pediátrica sars-cov-2 arnm tozinamerán)
pfizer chile s.a. - tozinameran - tozinamerÁn (1) 3,00 mcg - inmunización activa para prevenir la enfermedad por coronavirus 2019 (covid-19) causada por el virus sars-cov-2, en personas de 6 meses a 4 años de edad.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vacunas - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vacunas - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 y 5. 1 in product information document). el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.
tosamerin 15mg/5ml jarabe
laboratorio farmaceutico america s.r.ltda. - jarabe
tritaurin grifols e114 emulsion para perfusion
laboratorios grifols, s.a. - glucosa monohidrato, l-triptofano, glicina, taurina, aceite soja purificado, isoleucina, leucina, valina, lisina hidrocloruro, metionina, fenilalanina, treonina, alanina, arginina, histidina, prolina, serina, cisteina hidrocloruro hidratado, aspartico acido, glutamico acido, tirosina - excipientes: glicerol,oleato de sodio,hidroxido de sodio (e-524) - soluciones i.v. - soluciones para nutrición parenteral - combinaciones
tritaurin grifols e138 emulsion para perfusion
laboratorios grifols, s.a. - glucosa monohidrato, l-triptofano, glicina, taurina, aceite soja purificado, isoleucina, leucina, valina, lisina hidrocloruro, metionina, fenilalanina, treonina, alanina, arginina, histidina, prolina, serina, cisteina hidrocloruro hidratado, aspartico acido, glutamico acido, tirosina - excipientes: glicerol,oleato de sodio,hidroxido de sodio (e-524) - soluciones i.v. - soluciones para nutrición parenteral - combinaciones
smofkabiven central . emulsion para perfusion
fresenius kabi peru s.a. - droguerÍa - emulsion para perfusion - por gramo mg - - combinaciones